Bumrungrad Hospital Public Limited (BUGDF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Bumrungrad Hospital Publi...

PNK: BUGDF · Real-Time Price · USD
6.31
0.00 (0.00%)
At close: May 06, 2025, 10:00 PM

Bumrungrad Hospital Public Income Statement

Financials in THB. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
25.3B 25.68B 25.7B 26.04B 25.8B 25.34B 24.83B 23.78B 22.65B 20.72B 18.63B 15.85B 13.92B 12.46B 11.49B 11.47B 10.91B
Cost of Revenue
12.4B 12.5B 12.58B 12.86B 12.89B 12.89B 12.7B 12.26B 11.86B 11.1B 10.23B 9.11B 8.38B 7.73B 7.35B 7.39B 7.13B
Gross Profit
12.9B 13.17B 13.12B 13.18B 12.91B 12.44B 12.13B 11.52B 10.8B 9.62B 8.4B 6.74B 5.55B 4.73B 4.15B 4.08B 3.78B
Operating Income
8.79B 9.06B 8.96B 9.01B 8.86B 8.39B 8.24B 7.69B 7B 6.01B 4.9B 3.45B 2.3B 1.52B 847.6M 749.6M 516.34M
Interest Income
281.38M 279.47M 262.58M 226.92M 177.62M 140.95M 107.44M 79.9M 59.5M 45.95M 45.59M 50.99M 59.26M 68.78M 75.62M 89.09M 106.76M
Pretax Income
9.11B 9.44B 9.39B 9.4B 9.16B 8.64B 8.39B 7.81B 7.09B 6.05B 4.92B 3.44B 2.26B 1.46B 891.75M 779.85M 538.18M
Net Income
7.52B 7.77B 7.59B 7.59B 7.41B 7.01B 6.83B 6.38B 5.8B 4.94B 4B 2.8B 1.85B 1.22B 776.57M 702.11M 530.07M
Selling & General & Admin
4.24B 4.17B 4.17B 4.21B 4.19B 4.18B 4.09B 4.05B 3.95B 3.8B 3.59B 3.4B 3.35B 3.3B 3.32B 3.33B 3.29B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
-125.41M -60.12M -6.95M n/a n/a n/a -79.87M -125.15M -152.53M -186.97M -132.58M -161.22M -155.26M -144.1M -137.39M -53.59M -23.09M
Operating Expenses
4.11B 4.11B 4.16B 4.18B 4.07B 4.06B 3.89B 3.83B 3.79B 3.61B 3.46B 3.24B 3.19B 3.15B 3.18B 3.25B 3.21B
Interest Expense
8.25M 8.33M 7.4M 5.6M 4.02M 2.39M 1.85M 2.18M 2.47M 3.55M 29.13M 59.83M 90.33M 119.76M 125.12M 125.73M 126.85M
Selling & Marketing Expenses
718.5M 728.37M 725.22M 717.65M 699.46M 684.88M 677.52M 655.56M 628.5M 586.33M 520.92M 438.62M 396.78M 358.45M 338.34M 336.05M 312.64M
Cost & Expenses
16.51B 16.61B 16.74B 17.04B 16.96B 16.95B 16.58B 16.09B 15.65B 14.71B 13.68B 12.35B 11.57B 10.88B 10.53B 10.64B 10.34B
Income Tax Expense
1.53B 1.6B 1.73B 1.75B 1.7B 1.58B 1.51B 1.39B 1.26B 1.07B 863.67M 586.7M 371.52M 215.85M 106.39M 66.2M -4.39M
Shares Outstanding (Basic)
794.93M 794.91M 794.91M 794.91M 794.9M 795.77M 794.89M 794.88M 794.89M 795.77M 867.41M 867.41M 863.14M 794.69M 794.59M 794.59M 794.59M
Shares Outstanding (Diluted)
867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M 867.41M
EPS (Basic)
9.46 9.78 9.55 9.55 9.32 8.81 8.59 7.86 7.00 5.85 4.70 3.34 2.27 1.54 0.97 0.88 0.67
EPS (Diluted)
8.67 8.96 8.75 8.75 8.54 8.08 7.88 7.36 6.68 5.69 4.64 3.25 2.16 1.43 0.90 0.82 0.62
EBITDA
10.11B 10.38B 10.33B 10.29B 10.1B 9.64B 9.39B 8.85B 8.16B 7.13B 6.03B 4.6B 3.47B 2.72B 2.17B 2.04B 1.79B
EBIT
9.12B 9.44B 9.39B 9.4B 9.16B 8.64B 8.39B 7.81B 7.1B 6.05B 4.94B 3.5B 2.35B 1.58B 1.02B 905.58M 665.03M
Depreciation & Amortization
1.07B 1.08B 1.08B 1.08B 1.09B 1.1B 1.11B 1.11B 1.12B 1.12B 1.13B 1.14B 1.16B 1.18B 1.19B 1.2B 1.21B